Try our Advanced Search for more refined results

Ravgen, Inc. v. Natera, Inc. et al

  1. February 19, 2026

    Judge Affirms Literal Infringement In Ravgen's $57M Jury Win

    A Texas federal judge has upheld a jury's finding that genetic testing company Natera Inc. committed literal infringement of a patent held by Ravgen Inc., but said Ravgen's expert testimony wasn't enough to support the jury's finding of infringement under the doctrine of equivalents.

  2. January 16, 2024

    Jury Awards $57M To Ravgen In Genetic Test Patent Row

    A Texas federal jury found Tuesday afternoon that genetic testing company Natera infringed a patent from rival Ravgen, awarding the Maryland-based biotech firm $57 million in damages, according to both parties.

  3. January 11, 2024

    Natera Can't Escape Ravgen's Patent Infringement Suit

    A Texas federal judge has denied a bid from genetic testing business Natera Inc. for a win on its argument that it did not infringe claims in a patent owned by a small biotech business, saying Natera had a flawed argument on elements of those claims.

  4. December 11, 2023

    Patent Deals Don't Support $410M DNA Test Suit, Court Told

    A small biotech business plans to use the web of settlement agreements it has landed since netting a blockbuster jury verdict last year to ask jurors to award it $410 million early next year, though the bid is opening the company up to arguments that nobody wanted to buy its patents before getting dragged into court.

  5. February 16, 2023

    WDTX Judge Won't Send Ravgen Patent Suit Back To Albright

    A Texas federal judge has rebuffed a bid by biotechnology company Ravgen to transfer its genetic testing patent suit against a rival back to U.S. District Judge Alan Albright's courtroom after Ravgen, the patent owner, scored a nine-figure judgment there, citing concerns about "potential mischief" behind the requested venue change.